Skip to main content
Clinical Trials/NCT06033794
NCT06033794
Recruiting
Not Applicable

Applications of Near-infrared Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation: A Prospective Randomized Controlled Study

Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 site in 1 country100 target enrollmentMay 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fluorescence
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Enrollment
100
Locations
1
Primary Endpoint
success rate of IMA fluorescence imaging
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To investigate the accuracy of fluorescence angiography technique IMA classification and the impact of lymph node mapping technique on the dissection of No. 253 lymph nodes.

Detailed Description

Multiple studies, including randomized controlled trials (RCTs), have demonstrated that lymph node imaging techniques can effectively increase the number of harvested lymph nodes in gastric and colorectal cancer surgeries . However, there remains a scarcity of research specifically focused on the surgical procedure of fluorescent-guided clearance of No. 253 lymph nodes. Most existing studies have been retrospective analyses, and the need for prospective studies is evident. Further clinical research is crucial to explore the successful application of fluorescence lymph node imaging combined with indocyanine green (ICG) fluorescence angiography and its multifunctional fusion. To address this gap, investigators plan to conduct a randomized controlled trial comparing the outcomes between the use of ICG Fluorescence lymph node Imaging combined with Fluorescence angiography (FIFA group) and conventional techniques (non-ICG group) in laparoscopic rectal cancer surgery. Specifically, investigators focus will be on the preservation of the left colic artery (LCA) and the clearance of No. 253 lymph nodes. The primary objectives of our study are to simplify surgical procedures, enhance surgical safety, and provide substantial evidence for the further promotion and adoption of this technique.

Registry
clinicaltrials.gov
Start Date
May 1, 2023
End Date
May 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jianqiang Tang

Associate professor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients aged between 18 and 75 years
  • Colonoscopic biopsy confirmed colorectal adenocarcinoma
  • The tumor was located in the rectum or upper rectum, and the surgical method was Dxion
  • No local complications before operation (no obstruction, incomplete obstruction, no massive active bleeding, no perforation, abscess formation, no local invasion)
  • Preoperative imaging diagnosis was cT1-4aNxM0
  • The hematopoietic functions of heart, lung, liver, kidney and bone marrow meet the requirements of surgery and anesthesia
  • Sign the informed consent form

Exclusion Criteria

  • Previous surgical history of malignant colorectal tumors
  • The surgical methods were combined abdominoperineal resection, Hartman operation and ISR operation
  • There are contraindication of laparoscopic surgery, such as severe cardiopulmonary insufficiency
  • Patients who have undergone multiple abdominal and pelvic surgeries or extensive abdominal adhesion
  • Patients with intestinal obstruction, intestinal perforation, intestinal bleeding and other emergency operations
  • ASA grade ≥IV and/or ECOG physical status score ≥2 points
  • Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery
  • Have a history of serious mental illness
  • Patients with uncontrolled infection before operation

Outcomes

Primary Outcomes

success rate of IMA fluorescence imaging

Time Frame: From the beginning to the end of the surgery.

ICG solution was prepared at a concentration of 2.5 g/L. A dose of 0.05 mg-0.10 mg/kg body weight of ICG was administered intravenously through a peripheral or central vein. Before the injection of ICG, the fluorescence laparoscope was set to the original fluorescence mode to monitor the IMA region in real-time.Record the success or failure rate of IMA fluorescence imaging in the observation group. Classify the successful IMA fluorescence imaging results into four different types according to the Morro classification and calculate the proportion of each type in successful imaging.

Secondary Outcomes

  • Left colic artery retention rate(From the beginning to the end of the surgery.)
  • Operation time(From the beginning to the end of the surgery.)
  • Protective ostomy rate(From the beginning to the end of the surgery.)
  • Complication rate within 30 days after operation(within 30 days after operation.)
  • Incidence of IMA bleeding events(From the beginning to the end of the surgery.)
  • No.253 lymph node dissection time(From the beginning to the end of the surgery.)
  • Intraoperative blood loss(From the beginning to the end of the surgery.)
  • Assessment of postoperative anal function urinary function within 30 days(Assessment conducted once before surgery, on postoperative day 7, and on postoperative day 30.)
  • Measurement of residual urine volume in the bladder.(On the day the catheter was removed after surgery.)
  • Arterial development time(From the beginning to the end of the surgery.)

Study Sites (1)

Loading locations...

Similar Trials